Preinterventional peak monocyte count and in-stent intimal hyperplasia after coronary stent implantation in human coronary arteries

Clinical Cardiology

Volumn 28, Issue 11, 2005, Pages 512-518

  Hong, Young Joon ^a   Jeong, Myung Ho ^a,b   Lim, Sang Yup ^a   Lee, Sang Rok ^a   Kim, Kye Hun ^a   Sohn, Il Suk ^a   Park, Hyung Wook ^a   Kim, Ju Han ^a   Kim, Weon ^a   Ahn, Youngkeun ^a   Cho, Jeong Gwan ^a   Park, Jong Chun ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

^b Department of Cardiovascular Medicine ^*  (South Korea)

Author keywords

Coronary artery disease; Inflammation; Restenosis; Stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DALTEPARIN; TICLOPIDINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; CORRELATION ANALYSIS; FEMALE; HUMAN; IMPLANTATION; INFLAMMATION; INTRAVASCULAR ULTRASOUND; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; RESTENOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 27744433804     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960281105     Document Type: Article

References (29)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P: The BENESTENT Study Group: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489-495
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M: The Stent Restenosis Study Investigators: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496-501
3. Popma JJ, Califf RM, Topol EJ: Clincal trials of restenosis after coronary angioplasty. Circulation 1991;84:1426-1436
4. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB: Patterns and mechanisms of in-stent restenosis: A serial intravascular ultrasound study. Circulation 1996;94:1247-1254
5. Grewe PH, Deneke T, Machraoui A, Barmeyer J, Muller KM: Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimens. J Am Coll Cardiol 2000;35:157-163
6. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340:115-126
7. Fuster V, Badimon L, Badimon JJ, Chesebro J: The pathogenesis of coronary artery disease and acute coronary syndromes. N Engl J Med 1992;326:242-250
8. Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB: In-stent restenosis: Contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224-230
9. Rogers C, Welt FG, Karnovsky MJ, Edelman ER: Monocyte recruitment and neointimal hyperplasia in rabbits: Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996;16:1312-1318.
10. 2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA 1998;95:10134-10139
11. Egashira K, Zhao Q, Kataoka C, Ohtani K, Usui M, Charo IF, Nishida K, Inoue S, Katoh M, Ichiki T, Takeshita A: Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res 2002;90:1167-1172
12. Moreno PR, Bernardi VH, Lopez-Cuellar J, Newell JB, McMellon C, Gold HK, Palacios IF, Fuster V, Fallon JT: Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1996;94:3098-3102
13. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB: Expression and secretion of type beta transforming factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-6024
14. Languino LR, Duperray A, Joganic KJ, Fornaro M, Thornton GB, Altieri DC: Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition. Proc Natl Acad Sci USA 1995;92:1505-1509
15. Sukhova GK, Shi GP, Simon DI, Chapman HA, Libby P: Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J Clin Invest 1998;102:576-583
16. Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM: Platelet glycoprotein IIIa polymorphism and risk of coronary stent thrombosis. Lancet 1997;350:1217-1219
17. Nissen SE, Yock P: Intravascular ultrasound: Novel pathophysiological insights and current clinical applications. Circulation 2001;103:604-616
18. Sangiorgi G, Holmes DR Jr, Schwartz RS: Restenosis: Etiologies and prevention. In Evidence-Based Cardiology (Eds. Yusuf S, Camm AJ, Fallen EL, Gersh BJ), pp. 371-394. London, U.K: British Medical Journal, 2003
19. Sangiorgi G, Taylor AJ, Farb A, Carter AJ, Edwards WD, Holmes DR, Schwartz RS, Virmani R: Histopathology of postpercutaneous transluminal coronary angioplasty remodeling in human coronary arteries. Am Heart J 1999;138:681-687
20. Li C, Cantor WJ, Nili N, Robinson R, Fenkell L, Tran YL, Whittingham HA, Tsui W, Cheema AN, Sparkes JD, Pritzker K, Levy DE, Strauss BH: Arterial repair after stenting and the effects of GM6001, a matrix metalloproteinase inhibitor. J Am Coll Cardiol 2002;39:1852-1858
21. Bellas RE, Lee JS, Sonenshein GE: Expression of a constrictive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest 1995;96:2521-2527
22. Welt FGP, Rogers C: Inflammation and restenosis in the stent era. Arteriosder Thromb Vasc Biol 2002;22:1769-1776
23. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A, Altamura S, Ciliberto G, Rebuzzi AG, Crea F, Pepys MB, Maseri A: Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998;98:2370-2376
24. Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J: Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004;43:18-23
25. Libby P: Inflammation in atherosclerosis. Nature 2002;420:868-874
26. Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 1995;92:657-671
27. van der Wal AC, Becker AE, van der Loos CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44
28. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-369
29. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A: The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-424